About Contact Us Careers

Osteoarthritis Therapeutics Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 195
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Osteoarthritis Therapeutics Landscape

Sanofi-aventis Groupe
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc
Pfizer Inc.
Bayer AG
Zimmer Biomet Holdings, Inc.
Horizon Therapeutics plc
Johnson & Johnson Services, Inc.
Novartis AG
Ferring Group
Merck & Co., Inc

Browse Key Market Insights with Data Illustration:

Osteoarthritis Therapeutics Market Size & Share, Growth Report 2037

In the News

May 20, 2022: Pfizer Inc. joins hand with NetVation DL Medicine which is a privately held biotechnology company based in Chengdu.
April 28, 2022: Medtronic plc (MDT), a medical technology company, announced collaboration with GE to meet growing need for outpatient care.

Author Credits: Radhika Pawar

Report ID: 195
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of osteoarthritis therapeutics is evaluated at USD 9.84 billion.

Osteoarthritis Therapeutics Market size was valued at USD 9.31 billion in 2024 and is set to exceed USD 21.63 billion by 2037, registering over 6.7% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to dominate majority revenue share by 2037, on the back of presence of ultra-modern healthcare infrastructure in the region.

The major players in the market are Bayer AG, Horizon Therapeutics plc, and Johnson & Johnson Services, Inc.

Inquiry Before Buying Request Free Sample